A New Track Ablation Device for Liver Biopsy: A Feasibility Study

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness and safety of a new biopsy track ablation device for liver biopsy.

Clinical Trial Description

Background:

- Percutaneous biopsy for hepatic masses has a potential risk of bleeding and peritoneal tumor seeding.

- A new device for biopsy track ablation has been invented to reduce the risk of bleeding and peritoneal tumor seeding.

Method:

- Routine percutaneous biopsy for hepatic masses is performed.

- Immediate after obtaining tissue, biopsy needle track is ablated with a new biopsy tract ablator.

- Immediate (with ultrasound) and 24 hours (with CT scan) after procedure, occurrence of complications is evaluated. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Liver Neoplasms

Clinical Trial Details

NCT number	NCT02521129
Study type	Interventional
Source	Samsung Medical Center
Contact	Hyunchul Rhim, professor
Phone	82-2-3410-2507
Email	hc.rhim@samsung.com
Status	Not yet recruiting
Phase	Phase 1/Phase 2
Start date	September 2015
Completion date	February 2016

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03651154` - Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections	N/A
Not yet recruiting	`NCT03592550` - The eValuation of Image Guidance of Stereotactic Body Radiotherapy Using Ultrasound: Assessment in Liver
Not yet recruiting	`NCT02168608` - Remote Ischemia Precondition (RIPC) for Hepatic Protection in Patients Undergoing Hepatectomy	N/A
Enrolling by invitation	`NCT01465425` - Extracolonic Findings on Computed Tomography (CT) Colonography
Active, not recruiting	`NCT01177007` - Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors	Phase 2
Completed	`NCT00788697` - SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization	Phase 3
Recruiting	`NCT01564810` - Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer	Phase 4
Completed	`NCT00094003` - Study of NS-9 in Patients With Liver Metastases	Phase 1
Terminated	`NCT00051532` - Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma	N/A
Completed	`NCT00001587` - A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver	Phase 1
Completed	`NCT00222664` - Qidong Hepatitis B Intervention Study	Phase 4
Recruiting	`NCT04518852` - TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC	Phase 2
Completed	`NCT03289273` - Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)
Terminated	`NCT03349255` - Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma	Phase 1
Recruiting	`NCT05068180` - Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients	Phase 4
Recruiting	`NCT03715517` - Spinal Anesthesia For Enhanced Recovery After Liver Surgery	N/A
Terminated	`NCT03685591` - PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors	Phase 1
Terminated	`NCT01744054` - Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization	Phase 1
Active, not recruiting	`NCT02969096` - Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma	Phase 2
Recruiting	`NCT01214343` - Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC	Phase 3